Cargando…

Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder

PURPOSE: The overactive bladder (OAB) syndrome is characterized by urgency usually with frequency and nocturia. Tamsulosin, α(1)-adrenergic receptor antagonist, is widely used to reduce symptoms of urinary obstruction and prostatic hyperplasia. Tamsulosin can across the blood-brain barrier. We inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung-Eun, Shin, Mal-Soon, Kim, Chang-Ju, Park, Ji-Hyeon, Chung, Kyung-Jin, Jung, Han, Kim, Khae-Hawn, Lee, Jung-Hwan, Ko, Il-Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321398/ https://www.ncbi.nlm.nih.gov/pubmed/22500249 http://dx.doi.org/10.5213/inj.2012.16.1.13

Ejemplares similares

Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spinal Cord Injury
por: Han, Jin-Hee, et al.
Publicado: (2017)

An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil
por: Kim, Sung-Eun, et al.
Publicado: (2013)

A novel intracerebral hemorrhage-induced rat model of neurogenic voiding dysfunction: Analysis of lower urinary tract function
por: CHO, YOUNG-SAM, et al.
Publicado: (2015)

The Changes of Voiding Pattern After Midurethral Sling Between Pure Stress Urinary Incontinence and Stress Urinary Incontinence With Overactive Bladder Group
por: Kim, Sun Wook, et al.
Publicado: (2014)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

Urinary bladder rupture during voiding cystourethrography
por: Lee, Kyong Ok, et al.
Publicado: (2012)

Effects of Combination Treatment of Alpha 1-Adrenergic Receptor Antagonists on Voiding Dysfunction: Study on Target Organs in Overactive Bladder Rats
por: Ko, Il Gyu, et al.
Publicado: (2016)

Bladder Failure?
por: Kim, Khae Hawn, et al.
Publicado: (2012)

Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction
por: Cho, Kang Jun, et al.
Publicado: (2015)

Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats
por: Ko, Il-Gyu, et al.
Publicado: (2018)

Effect of Long-term Exercise on Voiding Functions in Obese Elderly Women
por: Ko, Il Gyu, et al.
Publicado: (2013)

Low-Dose Cyclophosphamide Induces Nerve Injury and Functional Overactivity in the Urinary Bladder of Rats
por: Wang, Rui, et al.
Publicado: (2021)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Oral mucosa stem cells alleviates spinal cord injury-induced neurogenic bladder symptoms in rats
por: Cho, Young-Sam, et al.
Publicado: (2014)

Association of Urinary Urgency and Delay Time of Micturition in Women With Overactive Bladder
por: Park, Kyung Kgi, et al.
Publicado: (2014)

Potential Use of Antiproliferative Factor as a Targeting Therapy in Painful Bladder Syndrome/Interstitial Cystitis
por: Kim, Khae Hawn
Publicado: (2011)

Irreversible Bladder Remodeling Induced by Fibrosis
por: Kim, Su Jin, et al.
Publicado: (2021)

The Add-On Effect of Solifenacin for Patients with Remaining Overactive Bladder after Treatment with Tamsulosin for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction
por: Masumori, Naoya, et al.
Publicado: (2010)

Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months
por: Kim, Su Jin, et al.
Publicado: (2022)

Efficacy and Safety of Propiverine in Children with Overactive Bladder
por: Kim, Woo Jung, et al.
Publicado: (2012)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
por: Ellsworth, Pamela
Publicado: (2009)

Detrusor-Overactivity-Related Voiding in Women Mimics Bladder Outflow Obstruction and Conceals Underactivity
por: Kitta, Takeya, et al.
Publicado: (2023)

Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
por: Cho, Young Sam, et al.
Publicado: (2016)

Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study
por: Kakizaki, Hidehiro, et al.
Publicado: (2020)

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients
por: Suh, Yoon Seok, et al.
Publicado: (2017)

The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder
por: Kim, Ji Hyun, et al.
Publicado: (2011)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Expression of Caveolin-1 in Rat Urinary Bladder with Cyclophosphamide-Induced Cystitis
por: Kim, Sun-Ouck, et al.
Publicado: (2012)

Presence of multiple peripheral circadian oscillators in the tissues controlling voiding function in mice
por: Noh, Jong-Yun, et al.
Publicado: (2014)

Urinary Microbiome and Psychological Factors in Women with Overactive Bladder
por: Wu, Peng, et al.
Publicado: (2017)

Swimming: Effects on Stress Urinary Incontinence and the Expression of Nerve Growth Factor in Rats Following Transabdominal Urethrolysis
por: Ko, Il Gyu, et al.
Publicado: (2011)

Factors affecting medication discontinuation in patients with overactive bladder symptoms
por: Shim, Eun-Jung, et al.
Publicado: (2015)

The Performance of the Xpert Bladder Cancer Monitor Test and Voided Urinary Cytology in the Follow-up of Urinary Bladder Tumors
por: Smrkolj, Tomaz, et al.
Publicado: (2020)

A comparison of normal and high post-void residual urine and urodynamic parameters in women with overactive bladder
por: Dağdeviren, Hediye, et al.
Publicado: (2017)

Recommendations to the primary care practitioners and the patients for managing pelvic pain, especially in painful bladder syndrome for early and better prognosis
por: Chung, Kyung Jin, et al.
Publicado: (2015)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study
por: Katoh, Takao, et al.
Publicado: (2020)

Adenosine A(2A) Receptor Agonist Polydeoxyribonucleotide Alleviates Interstitial Cystitis-Induced Voiding Dysfunction by Suppressing Inflammation and Apoptosis in Rats
por: Ko, Il-Gyu, et al.
Publicado: (2021)

Socioeconomic Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
por: Sung, Wooseuk, et al.
Publicado: (2012)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
por: Liao, Kuang-Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o2d7n1i1h1t4ic5artq9vo7p0q